Kindred Group plc’s (Kindred) Director of Corporate Development and Investor Relations, Patrick Kortman, has assumed the role of interim CFO as of 21st June.
Kindred’s previous CFO, Johan Wilsby, announced in May that he will leave the firm.
Patrick has been at Kindred since 2018 working closely with the Board, the Executive Team, and the Financial Department.
He also has extensive experience from the financial market having held senior positions at Nordea and Ratos.
“I am very pleased that Patrick has agreed to take on the role as Interim CFO at Kindred. Patrick knows Kindred very well and has a vast experience from the financial sector, and he will continue to bring great value to Kindred’s financial operations, to the wider Executive Team, and to the Board as we continue to focus on the strategic review,” says Nils Andén, Interim CEO at Kindred Group.
Johan Wilsby will continue to support the Executive Team until he leaves Kindred. In addition to the Interim CFO role, two additional interim appointments have been made to the Executive Team.
Usha Ganesan will assume the role as Interim Chief Finance Operations Officer, and Neil Banbury will assume the role as Interim Chief Commercial & Marketing Officer. All appointments will remain as interim until the strategic review is concluded. “I am delighted that we can maintain momentum and consistency across the company during this period thanks to our excellent senior leaders and strong employee base”, continues Nils Andén.
Nikos Zygouris was appointed Head of Sportsbook Product while Alfred Bashllari was appointed Sportsbook Product Consultant
The tool was developed with input from Caritas Malta, Aġenzija Sedqa, the OASI Foundation and the Responsible Gaming Foundation
This enhanced offering – spanning IT advisory, AI consultancy, and ISO implementation – reflects the firm’s focus on innovation, compliance, and sustainable digital growth
Dr Joanna Delia and Dr Gorana Pecotic discuss the evolution of aesthetics, their unwavering philosophy rooted in natural beauty and patient well-being, and their vision for the future.